Press Releases
August 11, 2010
Long-Term Experience With the DuraHEart Left-Ventricular Assist System Continues to Grow as Another Patient Surpasses Four Years of Support on the Device
April 20, 2010
DuraHeart™ Left Ventricular Assist System Is Focus For Terumo Heart, Inc, At International Society For Heart And Lung Transplantation Meeting
April 14, 2010
Terumo Heart, Inc. Submits IDE To FDA For U.S. Destination Therapy Trial For The Duraheart™ Left Ventricular Assist System
March 19, 2010
Terumo Unveils State-Of-The-Art Manufacturing Plant, Expanded Ann Arbor Headquarters To State Dignitaries As Symbols Of MEGA Grant Success
December 22, 2009
Heart Failure Patient Supported By DuraHeart™ Left-Ventricular Assist System Receives Successful Donor Transplant After Four Years on Device
November 17, 2009
Terumo Heart Wins Top Healthcare Catergory Honors At AnnArbor.com's 5th Annual "Deals of the Year" Awards Ceremony
October 14, 2009
DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery
October 6, 2009
Terumo Heart, Inc.'s DuraHeart™ Left-Ventricular Assist System Featured at Future of Health Technology Summit
August 3, 2009
Terumo Heart Names Tom Gould and Mark Bullivant to Senior Management Team
May 19, 2009
Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives The DuraHeart™ Left Ventricular Assist System
April 6, 2009
Study Data Show Positive European Experience with DuraHeart Left Ventricular Assist Device For Advanced Stage Heart Failure Patients
March 17, 2009
David Feldman, M.D. Appointed Co-Principal Investigator of Duraheart™ Left Ventricular Assist System U.S. Clinical Trial
March 9, 2009
Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart™ U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
January 16, 2009
Leading Surgeon to Present at Terumo STS Booth!
November 24, 2008
Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
October 21, 2008
Fifth DuraHeart™ U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
August 21, 2008
Discharge of First DuraHeart™ Patient
August 6, 2008
First DuraHeart™ Left Ventricular Assist System Implanted in the
U.S.Pivotal Trial
June 24, 2008
Terumo Heart obtains IRB approval from the University of
Michigan to Initiate DuraHeart Left Ventricular Assist System U.S. Pivotal
Trial
April 22, 2008
Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo
Heart, Inc.. presented current European results of DuraHeart at ISHLT in
April
March 3, 2008
Terumo Heart, Inc. announced today that they have received
conditional approval from the Food and Drug Administration (FDA) to begin
enrollment in the US Pivotal Trial of the DuraHeart
TM LVAS for a Bridge-to-Transplant (BTT)
indication.
September 17, 2007
Terumo Heart, Inc. announced today that it had a successful
European Launch Symposium at the European Association of Cardio-Thoracic
Surgeons (EACTS) meeting in Geneva, Switzerland.
September 5, 2007
Terumo Heart Inc. announced today that it is planning a European
Launch Symposium at the European Association of Cardio-Thoracic Surgeons
(EACTS) meeting in Geneva, Switzerland on September 17, 2007
February 27, 2007
Terumo Heart Inc. announced today that it has received a CE Mark
allowing the commercial distribution of the DuraHeart® Left Ventricular
Assist System within the European Community. The DuraHeart is the world’s
first magnetically levitated centrifugal LVAS to receive market approval
in Europe.